{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:06:19Z","timestamp":1784696779422,"version":"3.55.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Prostate cancer (PCa) is the most prevalent malignant tumor in the urogenital system among men worldwide. Due to its subtle early symptoms and strong tumor heterogeneity, traditional diagnostic methods relying on a single prostate-specific antigen (PSA) initial screening and subjective imaging evaluations often lead to high false positives, overt biopsies, and missed small lesions. The rapid development of artificial intelligence (AI) provides innovative solutions to overcome these clinical bottlenecks. This article comprehensively reviews the application of AI in the early intelligent diagnosis of PCa. In the fields of ultrasound, magnetic resonance imaging (MRI), and positron emission tomography\/computed tomography (PET\/CT) imaging, AI significantly enhances the accuracy of target lesion identification. It achieves this by deep decoding high-dimensional quantitative features and effectively reducing subjective bias. In non-invasive liquid biopsy, AI-driven multi-omics networks have successfully addressed challenging screening blind spots, such as the PSA gray zone. In light of current challenges such as limited model generalization capability and the \u201cblack box effect\u201d of algorithms, this article looks forward to the development prospects of constructing multimodal fusion models based on federated learning and explainable AI (XAI), aiming to promote the transition of PCa diagnosis and treatment from algorithm development to real clinical decision support.<\/jats:p>","DOI":"10.3389\/fonc.2026.1906810","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:43:54Z","timestamp":1784695434000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Artificial intelligence in the early diagnosis of prostate cancer: from multimodal imaging to liquid biopsy"],"prefix":"10.3389","volume":"16","author":[{"given":"Jun","family":"Xie","sequence":"first","affiliation":[{"name":"The First Clinical School of Chinese Medicine, Hunan University of Chinese Medicine","place":["Changsha, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Yin","sequence":"additional","affiliation":[{"name":"School of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine","place":["Changsha, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruisong","family":"Gao","sequence":"additional","affiliation":[{"name":"The First Hospital of Hunan University of Chinese Medicine","place":["Changsha, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zerui","family":"Qiu","sequence":"additional","affiliation":[{"name":"The First Clinical School of Chinese Medicine, Hunan University of Chinese Medicine","place":["Changsha, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[{"name":"The First Hospital of Hunan University of Chinese Medicine","place":["Changsha, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.48252","article-title":"An in-depth look into the epidemiological and etiological aspects of prostate cancer: A literature review","volume":"15","author":"Al-Ghazawi","year":"2023","journal-title":"Cureus"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.48252","article-title":"An in-depth look into the epidemiological and etiological aspects of prostate cancer: A literature review","volume":"15","author":"Al-Ghazawi","year":"2023","journal-title":"Cureus"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer\u20142024 update. Part I: Screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18101547","article-title":"Prostate cancer screening in contemporary era: PSA-based testing and risk-adapted approaches","volume":"18","author":"Brancaccio","year":"2026","journal-title":"Cancers"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-025-01090-y","article-title":"End of the TRUS era: Transperineal biopsy takes the lead in prostate cancer detection","volume":"23","author":"Hennes","year":"2025","journal-title":"Nat Rev Urol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.70189","article-title":"Artificial intelligence in prostate MRI: Addressing current limitations through emerging technologies","volume":"63","author":"Johnson","year":"2026","journal-title":"J Magn Reson Imaging"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10278-025-01782-2","article-title":"Precision risk stratification in prostate cancer: Unveiling MRI-based habitat-driven radiomics model for enhanced treatment guidance","author":"Qiu","year":"2025","journal-title":"J Imaging Inf Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.20944\/preprints202311.1366.v1","article-title":"How artificial intelligence is shaping medical imaging technology: A survey of innovations and applications","volume":"10","author":"Pinto-Coelho","year":"2023","journal-title":"Bioengineering"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s10278-025-01804-z","article-title":"Handcrafted vs. deep radiomics vs. fusion vs. deep learning: A comprehensive review of machine learning -based cancer outcome prediction in PET and SPECT imaging","author":"Salmanpour","year":"2026","journal-title":"J Imaging Inf Med"},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.1109\/ICFTS62006.2025.11031724","article-title":"Deep learning in radiology: Challenges and opportunities for improved diagnosis","author":"Rasuli","year":"2025"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s13244-018-0639-9","article-title":"Convolutional neural networks: An overview and application in radiology","volume":"9","author":"Yamashita","year":"2018","journal-title":"Insights into Imaging"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-023-04002-z","article-title":"PSMA PET imaging in the diagnosis and management of prostate cancer","volume":"48","author":"Houshmand","year":"2023","journal-title":"Abdominal Radiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S265058","article-title":"Transrectal ultrasound in prostate cancer: Current utilization, integration with mpMRI, HIFU and other emerging applications","volume":"14","author":"Panzone","year":"2022","journal-title":"Cancer Manag Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/postmj\/qgad127","article-title":"An artificial intelligence model based on transrectal ultrasound images of biopsy needle tract tissues to differentiate prostate cancer","volume":"100","author":"Li","year":"2024","journal-title":"Postgrad Med J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102027","article-title":"Three-dimensional convolutional neural network model to identify clinically significant prostate cancer in transrectal ultrasound videos: A prospective, multi-institutional, diagnostic study","volume":"60","author":"Sun","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.718155","article-title":"A fully automatic artificial intelligence system able to detect and characterize prostate cancer using multiparametric MRI: Multicenter and multi-scanner validation","volume":"11","author":"Giannini","year":"2021","journal-title":"Front Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-022-03419-2","article-title":"Deep learning-based artificial intelligence for prostate cancer detection at biparametric MRI","volume":"47","author":"Mehralivand","year":"2022","journal-title":"Abdominal Radiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1109\/ACCESS.2023.3326882","article-title":"SAM-UNETR: Clinically significant prostate cancer segmentation using transfer learning from large model","volume":"11","author":"Alzate-Grisales","year":"2023","journal-title":"IEEE Access"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.27599","article-title":"A deep learning approach to diagnostic classification of prostate cancer using pathology-radiology fusion","volume":"54","author":"Khosravi","year":"2021","journal-title":"J Magn Reson Imaging"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14176111","article-title":"Artificial intelligence-assisted biparametric MRI for detecting prostate cancer-a comparative multireader multicase accuracy study","volume":"14","author":"Ni\u00dfler","year":"2025","journal-title":"J Clin Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00220-1","article-title":"Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): An international, paired, non-inferiority, confirmatory study","volume":"25","author":"Saha","year":"2024","journal-title":"Lancet Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fnume.2022.825512","article-title":"Normal variants, pitfalls, and artifacts in Ga-68 prostate specific membrane antigen (PSMA) PET\/CT imaging","volume":"2","author":"Malan","year":"2022","journal-title":"Front Nucl Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2023.06.001","article-title":"Applications of artificial intelligence in PSMA PET\/CT for prostate cancer imaging","volume":"54","author":"Lindgren Belal","year":"2024","journal-title":"Semin Nucl Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13550-022-00948-1","article-title":"Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET","volume":"12","author":"Leung","year":"2022","journal-title":"EJNMMI Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-023-06551-3","article-title":"Deep learning\u2013based whole-body characterization of prostate cancer lesions on [68Ga]Ga-PSMA-11 PET\/CT in patients with post-prostatectomy recurrence","volume":"51","author":"Huang","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2196\/60323","article-title":"A machine learning approach for predicting biochemical outcome after PSMA-PET\u2013guided salvage radiotherapy in recurrent prostate cancer after radical prostatectomy: Retrospective study","volume":"10","author":"Janbain","year":"2024","journal-title":"JMIR Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.juro.2013.02.3184","article-title":"Head-to-head comparison of prostate health index and urinary PCA3 for predicting cancer at initial or repeat biopsy","volume":"190","author":"Scattoni","year":"2013","journal-title":"J Urol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12885-026-15577-3","article-title":"Prostate health index enhances prostate cancer management in Chinese populations: Evidence from the nation\u2019s large cohort and transnational multicohort harmonization","volume":"26","author":"Zhong","year":"2026","journal-title":"BMC Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2209454","article-title":"Prostate cancer screening with PSA and MRI followed by targeted biopsy only","volume":"387","author":"Hugosson","year":"2022","journal-title":"N Engl J Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3390\/cancers15041166","article-title":"Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination","volume":"15","author":"Frantzi","year":"2023","journal-title":"Cancers"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110330","article-title":"Prostate cancer detection through unbiased capture of methylated cell-free DNA","volume":"27","author":"Lleshi","year":"2024","journal-title":"iScience"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1038\/s41598-025-32334-x","article-title":"Prostate cancer diagnosis using sensitive and sophisticated machine learning classifiers based on non-invasive urinary RNA biomarkers (PCASSO)","volume":"16","author":"Goh","year":"2025","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.e17095","article-title":"Stratification of patients with prostate cancer using a comprehensive multiomic approach: Integrating extracellular vesicle transcriptomics profiling with cfDNA methylation in urine-based liquid biopsy","volume":"42","author":"Miller","year":"2024","journal-title":"J Clin Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1763766","article-title":"Construction and validation of a multimodal MRI-based deep learning model for early differential diagnosis of prostate cancer in the PSA gray zone: A retrospective cohort study","volume":"16","author":"Xu","year":"2026","journal-title":"Front Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocac141","article-title":"A smart, practical, deep learning-based clinical decision support tool for patients in the prostate-specific antigen gray zone: Model development and validation","volume":"29","author":"Song","year":"2022","journal-title":"J Am Med Inf Assoc"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1763359","article-title":"Multimodal artificial intelligence in urologic precision oncology: From algorithm to translational medicine (a systemized narrative review)","volume":"16","author":"Rajaee Rizi","year":"2026","journal-title":"Front Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2196\/58080","article-title":"Exploring impediments imposed by the medical device regulation EU 2017\/745 on software as a medical device","volume":"12","author":"Svempe","year":"2024","journal-title":"JMIR Med Inf"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1906810\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:44:15Z","timestamp":1784695455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1906810\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":39,"alternative-id":["10.3389\/fonc.2026.1906810"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1906810","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"1906810"}}